Dr Rachel Elizabeth Easter, MD | |
1906 Belleview Ave Se, Roanoke, VA 24014-1838 | |
(540) 981-7000 | |
Not Available |
Full Name | Dr Rachel Elizabeth Easter |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1906 Belleview Ave Se, Roanoke, Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164127502 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Dr Rachel Elizabeth Easter, MD 1906 Belleview Ave Se, Roanoke, VA 24014-1838 Ph: (540) 981-7000 | Dr Rachel Elizabeth Easter, MD 1906 Belleview Ave Se, Roanoke, VA 24014-1838 Ph: (540) 981-7000 |
News Archive
Teva Pharmaceutical Industries Ltd. and Active Biotech announced today that they have amended the marketing and distribution agreement for oral laquinimod, an investigational treatment for relapsing-remitting multiple sclerosis (RRMS). Under the new agreement, Teva extended its marketing and distribution rights to include the Nordic and Baltic regions, previously held by Active Biotech. Active Biotech will receive a higher royalty rate for sales in these territories compared to the royalty rate set under the original licensing agreement signed in 2004 for sales in the rest of the world.
CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Meenakshi Mission Hospital and Research Centre in Madurai, Tamil Nadu, India, the first clinical site in India.
A gene that is associated with osteoarthritis and skeletal deformities in people has been shown to be responsible for preventing the onset of osteoarthritis in adult mice, according to a recent study led by Rhode Island Hospital.
An emerging discipline of noninvasive cardiac imaging, molecular imaging, has evolved constantly in the last few years and is increasingly being translated from the preclinical to the clinical level.
Doctor Elena Zubillaga studied 109 women and 120 men admitted to hospital with a cardiac insufficiency solely due to high blood pressure. More concretely, she analysed the clinical, biochemical and ecocardiographical differences between the patients, depending on their sex. She also made reference to the data provided by serum markers for the metabolism of the collagen in the heart and the systolic function or contraction of the latter, as alterations taking place in the metabolism of myocardial collagen are associated with certain clinical situations.
› Verified 8 days ago